We are live on ! Find out more
ANIX icon

Anixa Biosciences
ANIX

55 hedge funds and large institutions have $17.3M invested in Anixa Biosciences in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 5

35% more capital invested

Capital invested by funds: $12.8M → $17.3M (+$4.45M)

12% more funds holding

Funds holding: 49 → 55 (+6)

1.7% more ownership

Funds ownership: 12.64% → 14.35% (+1.7%)

9% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 11

28% less call options, than puts

Call options by funds: $159K | Put options by funds: $220K

Holders
55
Holders Change
+6
Holders Change %
+12.24%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
12
Reduced
11
Closed
5
Calls
$159K
Puts
$220K
Net Calls
-$61K
Net Calls Change
-$265K

Top Buyers

Rank Fund Capital Flow
1
LNWTC
Laird Norton Wetherby Trust Company
Washington
+$1.24M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$163K
3
Jane Street
Jane Street
New York
+$146K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$124K
5
Morgan Stanley
Morgan Stanley
New York
+$122K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$80.5K
2
UBS Group
UBS Group
Switzerland
-$80.5K
3
JP Morgan Chase
JP Morgan Chase
New York
-$68.9K
4
BCM
Bridgeway Capital Management
Texas
-$68.7K
5
Squarepoint
Squarepoint
New York
-$44.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
SS
26
Simplicity Solutions
Minnesota
$60K – – –
DWM
27
Dakota Wealth Management
Florida
$58.2K – – –
NFG
28
Nations Financial Group
Iowa
$58.2K – – –
YIH
29
Y-Intercept (HK)
Hong Kong
$55.8K +$48.5K +14,372 New
IAIM
30
International Assets Investment Management
Florida
$54.3K -$1.69K -500 -3%
WIM
31
Westside Investment Management
California
$53.9K +$3.37K +1,000 +8%
HighTower Advisors
32
HighTower Advisors
Illinois
$52K +$45.6K +13,523 New
Charles Schwab
33
Charles Schwab
California
$49.6K – – –
VF
34
Virtu Financial
New York
$43K +$37K +10,973 New
Marshall Wace
35
Marshall Wace
United Kingdom
$41.4K +$36K +10,675 New
SJGA
36
Stephen J. Garry & Associates
New York
$39.1K +$34K +10,080 New
JP Morgan Chase
37
JP Morgan Chase
New York
$26.6K -$68.9K -20,432 -75%
ASN
38
Advisory Services Network
Georgia
$24K +$20.8K +6,174 New
TWM
39
Tradition Wealth Management
Minnesota
$22K – – –
PNC Financial Services Group
40
PNC Financial Services Group
Pennsylvania
$11.8K – – –
TRCT
41
Tower Research Capital (TRC)
New York
$10.5K -$44K -13,060 -83%
LFA
42
Livelsberger Financial Advisory
Ohio
$6.34K +$5.51K +1,634 New
AA
43
Ancora Advisors
Ohio
$5.91K – – –
Citigroup
44
Citigroup
New York
$5.9K +$5.13K +1,520 New
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$5K +$115 +34 +3%
Group One Trading
46
Group One Trading
Illinois
$4.99K -$1.05K -312 -20%
PS
47
Principal Securities
Iowa
$3.88K +$3.37K +1,000 New
Wells Fargo
48
Wells Fargo
California
$2.87K +$44 +13 +2%
LFG
49
Larson Financial Group
Missouri
$2.04K – – –
PCC
50
Park Circle Company
Maryland
$1.94K – – –
1
2
3

ANIX Hedge Fund Activity: Q4 2023 in Review

55 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q4 2023, worth a combined $17.3M — up 35% from $12.8M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ANIX positions and 5 closed out — a net gain of 6 holders — while 12 added to existing stakes and 11 trimmed.

The largest buyer was Laird Norton Wetherby Trust Company, opening a new position worth an estimated $1.24M. The largest seller was Citadel Advisors, cutting an estimated $80.5K.

  • 55 institutional investors held Anixa Biosciences (ANIX) as of Q4 2023, up from 49 in Q3 2023.
  • Funds reported $17.3M of Anixa Biosciences stock for Q4 2023, up 35% quarter-over-quarter.
  • 11 funds opened new Anixa Biosciences positions in Q4 2023 and 5 closed out, a net change of +6 holders.
  • The largest Anixa Biosciences buyer in Q4 2023 was Laird Norton Wetherby Trust Company, an estimated $1.24M added.
  • The largest Anixa Biosciences seller in Q4 2023 was Citadel Advisors, an estimated $80.5K sold.

Based on aggregated 13F filings for Q4 2023.